HAE
Haemonetics CorporationNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$3.08B
P/E Ratio
33.08
EPS
$2.05
Beta
0.53
52W High
$87.32
52W Low
$47.32
50-Day MA
$58.79
200-Day MA
$62.46
Dividend Yield
—
Profit Margin
7.29%
Forward P/E
12.99
PEG Ratio
1.08
About Haemonetics Corporation
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $1.33B |
| Gross Profit (TTM) | $792.87M |
| EBITDA | $357.15M |
| Operating Margin | 13.90% |
| Return on Equity | 12.00% |
| Return on Assets | 6.49% |
| Revenue/Share (TTM) | $28.28 |
| Book Value | $19.46 |
| Price-to-Book | 3.87 |
| Price-to-Sales (TTM) | 2.31 |
| EV/Revenue | 3.044 |
| EV/EBITDA | 15.13 |
| Quarterly Earnings Growth (YoY) | 28.40% |
| Quarterly Revenue Growth (YoY) | 4.80% |
| Shares Outstanding | $45.45M |
| Float | $44.88M |
| % Insiders | 1.61% |
| % Institutions | 107.98% |
Historical Volatility
HV 10-Day
37.47%
HV 20-Day
55.55%
HV 30-Day
47.56%
HV 60-Day
39.66%
HV Rank
74.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($81.60 target)
4
Strong Buy3
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 6/1/2026